Menu
Back to Journals » Infection and Drug Resistance » Volume 14
In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii [Corrigendum]
Zhang H, Zhu Y, Yang N, et al. Infect Drug Resist. 2021;14:4657–4666.
Page 4660, Table 1, Notes: section, the text “RIF, susceptible ≤2, resistant ≥4 (according to Working Party Report of BSAC);” should read “RIF, susceptible ≤2, resistant ≥4 (breakpoints based on Tan et al37 and Bai et al38);”.
The authors also wish to add the following two references to the end of the reference section on page 4666.
37. Tan TY, Ng LS, Poh K. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2. Diagn Microbiol Infect Dis. 2007;58(3):357-361. doi:10.1016/j.diagmicrobio.2007.02.008
38. Bai Y, Liu B, Wang T, et al. In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2015;59(3):1466-1471. doi:10.1128/AAC.04089-14
The authors apologize for this error.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.